Catalyst Wire Dossier Catalyst Wire Dossier

Armisarte

pemetrexed diacid monohydrate · Actavis Group PTC ehf
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Armisarte, covering 2025-07-25 to 2025-07-25. Get the full timeline:

Most recent: EMA Authorised: Armisarte (previously Pemetrexed Actavis) (pemetrexed diacid monohydrate) — Actavis Group PTC ehf

See pricing